These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24263694)

  • 1. Clinical application of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: comparison with brain perfusion SPECT.
    Takahashi H; Ishii K; Hosokawa C; Hyodo T; Kashiwagi N; Matsuki M; Ashikaga R; Murakami T
    AJNR Am J Neuroradiol; 2014 May; 35(5):906-11. PubMed ID: 24263694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head-to-Head Visual Comparison between Brain Perfusion SPECT and Arterial Spin-Labeling MRI with Different Postlabeling Delays in Alzheimer Disease.
    Kaneta T; Katsuse O; Hirano T; Ogawa M; Yoshida K; Odawara T; Hirayasu Y; Inoue T
    AJNR Am J Neuroradiol; 2017 Aug; 38(8):1562-1568. PubMed ID: 28572147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
    Imabayashi E; Matsuda H; Asada T; Ohnishi T; Sakamoto S; Nakano S; Inoue T
    J Nucl Med; 2004 Sep; 45(9):1450-7. PubMed ID: 15347711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of suspected Alzheimer's disease is improved by automated analysis of regional cerebral blood flow.
    Tang BN; Minoshima S; George J; Robert A; Swine C; Laloux P; Borght TV
    Eur J Nucl Med Mol Imaging; 2004 Nov; 31(11):1487-94. PubMed ID: 15232656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?
    Kubota T; Ushijima Y; Yamada K; Okuyama C; Kizu O; Nishimura T
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):414-21. PubMed ID: 15821961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.
    Kilroy E; Apostolova L; Liu C; Yan L; Ringman J; Wang DJ
    J Magn Reson Imaging; 2014 Apr; 39(4):931-9. PubMed ID: 24038544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined angiography and perfusion using radial imaging and arterial spin labeling.
    Okell TW
    Magn Reson Med; 2019 Jan; 81(1):182-194. PubMed ID: 30024066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study utilizing MRI 3D TGSE PASL (arterial spin labeling) differentiating clearance rates of labeled protons in the CNS of patients with early Alzheimer disease from normal subjects.
    Joseph CR; Benhatzel CM; Stern LJ; Hopper OM; Lockwood MD
    MAGMA; 2020 Aug; 33(4):559-568. PubMed ID: 31897905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring Cerebrovascular Reactivity through the Use of Arterial Spin Labeling in Patients with Moyamoya Disease.
    Yun TJ; Paeng JC; Sohn CH; Kim JE; Kang HS; Yoon BW; Choi SH; Kim JH; Lee HY; Han MH; Zaharchuk G
    Radiology; 2016 Jan; 278(1):205-13. PubMed ID: 26197057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 3D pseudo-continuous arterial spin labeling to characterize sex and age differences in cerebral blood flow.
    Liu W; Lou X; Ma L
    Neuroradiology; 2016 Sep; 58(9):943-8. PubMed ID: 27380039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-labeled pseudo-continuous arterial spin labeling (ASL) features between young and elderly adults: special reference to parameter selection.
    Fujiwara Y; Matsuda T; Kanamoto M; Tsuchida T; Tsuji K; Kosaka N; Adachi T; Kimura H
    Acta Radiol; 2017 Jan; 58(1):84-90. PubMed ID: 26893213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-assisted system for diagnosing degenerative dementia using cerebral blood flow SPECT and 3D-SSP: a multicenter study.
    Ishii K; Ito K; Nakanishi A; Kitamura S; Terashima A
    Jpn J Radiol; 2014 Jul; 32(7):383-90. PubMed ID: 24838777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of segmented 3D acquisition schemes for whole-brain high-resolution arterial spin labeling at 3 T.
    Vidorreta M; Balteau E; Wang Z; De Vita E; Pastor MA; Thomas DL; Detre JA; Fernández-Seara MA
    NMR Biomed; 2014 Nov; 27(11):1387-96. PubMed ID: 25263944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional whole-brain perfusion quantification using pseudo-continuous arterial spin labeling MRI at multiple post-labeling delays: accounting for both arterial transit time and impulse response function.
    Qin Q; Huang AJ; Hua J; Desmond JE; Stevens RD; van Zijl PC
    NMR Biomed; 2014 Feb; 27(2):116-28. PubMed ID: 24307572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric measurement of perfusion and arterial transit delay using hadamard encoded continuous arterial spin labeling.
    Dai W; Shankaranarayanan A; Alsop DC
    Magn Reson Med; 2013 Apr; 69(4):1014-22. PubMed ID: 22618894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.
    Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
    Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.